Showing results (1-10 of 269) with videos related to

Sort By:
Pageof 27
Biological Psychiatry|December 1, 1982
Relationships in healthy volunteers between secretion of monoamine metabolites in urine, and family history of psychiatric morbidityF A Wiesel, B Fyrö, H Nybäck, et al.
The British Journal of Psychiatry : the Journal of Mental Science|April 1, 1980
Relationships in healthy volunteers between concentrations of monoamine metabolites in cerebrospinal fluid and family history of psychiatric morbidityG Sedvall, B Fyrö, B Gullberg, et al.
Psychopharmacology|July 28, 1976
A mass fragmentographic method for the determination of chlorpromazine and two of its active metabolites in human plasma and CSFG Alfredsson, B Wode-Helgodt, G Sedvall
Acta Psychiatrica Scandinavica|August 1, 1977
Effect of chlorpromazine treatment on monoamine metabolite levels in cerebrospinal fluid of psychotic patientsB Wode-Helgodt, B Fyrö, B Gullberg, et al.
Acta Psychiatrica Scandinavica|August 1, 1978
Clinical effects and drug concentrations in plasma and cerebrospinal fluid in psychotic patients treated with fixed doses of chlorpromazineB Wode-Helgodt, S Borg, B Fyrö, et al.
Journal of Neurochemistry|March 1, 1984
Amino acids in plasma and CSF and monoamine metabolites in CSF: interrelationship in healthy subjectsL Hagenfeldt, L Bjerkenstedt, G Edman, et al.
The British Journal of Psychiatry : the Journal of Mental Science|September 1, 1985
Plasma amino acids in relation to cerebrospinal fluid monoamine metabolites in schizophrenic patients and healthy controlsL Bjerkenstedt, G Edman, L Hagenfeldt, et al.
Acta Psychiatrica Scandinavica|October 1, 1977
Effect of chlorpromazine treatment on prolactin levels in cerebrospinal fluid and plasma of psychotic patientsB Wode-Helgodt, P Eneroth, B Fyrö, et al.
Acta Psychiatrica Scandinavica. Supplementum|January 1, 1984
Time course for effects of sulpiride and chlorpromazine on monoamine metabolite and prolactin levels in cerebrospinal fluid from schizophrenic patientsC Härnryd, L Bjerkenstedt, B Gullberg, et al.
Psychopharmacology|January 1, 1985
Clinical and biochemical effects of citalopram, a selective 5-HT reuptake inhibitor--a dose-response study in depressed patientsL Bjerkenstedt, G Edman, L Flyckt, et al.
Pageof 27